Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phoebe Rich

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Archives of Dermatology|November 23, 2011
A new classification system for grading the severity of onychomycosis: Onychomycosis Severity IndexCaitlin Carney, Antonella Tosti, Ralph Daniel, et al.
Cutis|June 15, 2013
Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled studyMichael Jarratt, Terry Jones, Steven Kempers, et al.
Journal of the American Academy of Dermatology|November 10, 2015
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)Phoebe Rich, Melinda Gooderham, Hervé Bachelez, et al.
Journal of the American Academy of Dermatology|August 28, 2002
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled studyJohn K Geisse, Phoebe Rich, Amit Pandya, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 15, 2019
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper ExtremitiesShang I Brian Jiang, Steven Kempers, Phoebe Rich, et al.
The Journal of Clinical and Aesthetic Dermatology|November 21, 2015
Aesthetic Dermatologic Treatments: Consensus from the ExpertsW Philip Werschler, Jacqueline M Calkin, David A Laub, et al.
JAAD International|December 15, 2025
A randomized, double-blind, phase 3 study to compare efficacy, safety, and immunogenicity between DMB-3115 and reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasisKamelia Vekovska, Beata Imko-Walczuk, Martin Tichý, et al.
Dermatology and Therapy|January 1, 2023
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyStephen K Tyring, Phoebe Rich, Yayoi Tada, et al.
Journal of the American Academy of Dermatology|March 21, 2007
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJames Q Del Rosso, Guy F Webster, Mark Jackson, et al.
The Journal of Rheumatology|August 3, 2013
Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meetingApril W Armstrong, Laura C Coates, Luis R Espinoza, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Archives of Dermatology|November 23, 2011
A new classification system for grading the severity of onychomycosis: Onychomycosis Severity IndexCaitlin Carney, Antonella Tosti, Ralph Daniel, et al.
Cutis|June 15, 2013
Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled studyMichael Jarratt, Terry Jones, Steven Kempers, et al.
Journal of the American Academy of Dermatology|November 10, 2015
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)Phoebe Rich, Melinda Gooderham, Hervé Bachelez, et al.
Journal of the American Academy of Dermatology|August 28, 2002
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled studyJohn K Geisse, Phoebe Rich, Amit Pandya, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 15, 2019
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper ExtremitiesShang I Brian Jiang, Steven Kempers, Phoebe Rich, et al.
The Journal of Clinical and Aesthetic Dermatology|November 21, 2015
Aesthetic Dermatologic Treatments: Consensus from the ExpertsW Philip Werschler, Jacqueline M Calkin, David A Laub, et al.
JAAD International|December 15, 2025
A randomized, double-blind, phase 3 study to compare efficacy, safety, and immunogenicity between DMB-3115 and reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasisKamelia Vekovska, Beata Imko-Walczuk, Martin Tichý, et al.
Dermatology and Therapy|January 1, 2023
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyStephen K Tyring, Phoebe Rich, Yayoi Tada, et al.
Journal of the American Academy of Dermatology|March 21, 2007
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJames Q Del Rosso, Guy F Webster, Mark Jackson, et al.
The Journal of Rheumatology|August 3, 2013
Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meetingApril W Armstrong, Laura C Coates, Luis R Espinoza, et al.
Pageof 9